A symposium for UK market access leaders The healthcare landscape is continuously evolving, and the need for effective collaboration between the NHS and industry partners has never been more critical....
Read More
Louise Maddison joined Mtech Access as a Senior Consultant in our Market Access Team, earlier this year. Here, she talks about her career journey and her experiences since joining Mtech Access.
Discover how data visualisation dashboards can aid field teams in market access discussions with customers Healthcare leaders look to real-world data (RWD) to inform decisions. Field teams presenting decision-makers with...
Read More
Calum Jones (Associate Director – Health Economics) shares his experience speaking at the 2024 HTAi Conference. Calum participated in the panel discussion: ‘Surrogate Endpoints in Health Technology Assessment (HTA): From Trials to Economic Evaluations’.
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access stakeholders and processes for medical devices in key European markets’ is now available. Our...
Read More
What’s involved in conducting a systematic review? Our evidence experts outline the 7 stages for developing a HTA-ready gold-standard systematic literature review.
Are you a global market access lead looking to understand the challenges faced by your UK affiliates? Or do you work at a national level with responsibility for bringing a...
Read More
What can we expect to see in primary care in the NHS given recent policy announcements and ongoing uncertainty? What does the new GP Contract tell us about the future...
Read More
Hannah Palin (Director – Market Access) and Calum Jones (Associate Director – Health Economics) explore the landscape for economic evaluation in the US and highlight important considerations for companies seeking to infiltrate this key market.
We delve into ICER’s influence on drug pricing and access in the US. We also explore the importance of maximising engagement with ICER for favourable pricing and access outcomes.
